216 related articles for article (PubMed ID: 7775712)
1. Hirudin: initial results in acute myocardial infarction, unstable angina and angioplasty.
Cannon CP; Braunwald E
J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):30S-37S. PubMed ID: 7775712
[TBL] [Abstract][Full Text] [Related]
2. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
Carswell CI; Plosker GL
Drugs; 2002; 62(5):841-70. PubMed ID: 11929334
[TBL] [Abstract][Full Text] [Related]
3. Hirudin in Acute Myocardial Infarction.
Cannon CP
J Thromb Thrombolysis; 1995; 1(3):259-267. PubMed ID: 10608003
[TBL] [Abstract][Full Text] [Related]
4. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
[TBL] [Abstract][Full Text] [Related]
5. Potential advantages of direct-acting thrombin inhibitors.
Philippides GJ; Loscalzo J
Coron Artery Dis; 1996 Jul; 7(7):497-507. PubMed ID: 8913677
[No Abstract] [Full Text] [Related]
6. Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.
Topol EJ; Fuster V; Harrington RA; Califf RM; Kleiman NS; Kereiakes DJ; Cohen M; Chapekis A; Gold HK; Tannenbaum MA
Circulation; 1994 Apr; 89(4):1557-66. PubMed ID: 8149521
[TBL] [Abstract][Full Text] [Related]
7. Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.
Antman EM
Circulation; 1994 Oct; 90(4):1624-30. PubMed ID: 7923644
[TBL] [Abstract][Full Text] [Related]
8. Hirudin and hirudin analogues as new anticoagulant agents.
Pineo GF; Hull RD
Curr Opin Hematol; 1995 Sep; 2(5):380-5. PubMed ID: 9372023
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712
[TBL] [Abstract][Full Text] [Related]
10. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of hirudin and its derivatives. Potential clinical advantages over heparin.
Monreal M; Costa J; Salva P
Drugs Aging; 1996 Mar; 8(3):171-82. PubMed ID: 8720743
[TBL] [Abstract][Full Text] [Related]
12. Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina.
Rupprecht HJ; Terres W; Ozbek C; Luz M; Jessel A; Hafner G; vom Dahl J; Kromer EP; Prellwitz W; Meyer J
J Am Coll Cardiol; 1995 Dec; 26(7):1637-42. PubMed ID: 7594097
[TBL] [Abstract][Full Text] [Related]
13. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes.
Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators
N Engl J Med; 1996 Sep; 335(11):775-82. PubMed ID: 8778585
[TBL] [Abstract][Full Text] [Related]
14. Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial.
Yusuf S
Am J Cardiol; 1999 Sep; 84(5A):20M-25M. PubMed ID: 10505539
[TBL] [Abstract][Full Text] [Related]
15. GUSTO II trial.
Aylward P
Aust N Z J Med; 1993 Dec; 23(6):766-8. PubMed ID: 8141723
[TBL] [Abstract][Full Text] [Related]
16. Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK).
Neuhaus KL; von Essen R; Tebbe U; Jessel A; Heinrichs H; Mäurer W; Döring W; Harmjanz D; Kötter V; Kalhammer E
Circulation; 1994 Oct; 90(4):1638-42. PubMed ID: 7923646
[TBL] [Abstract][Full Text] [Related]
17. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
Direct Thrombin Inhibitor Trialists' Collaborative Group
Lancet; 2002 Jan; 359(9303):294-302. PubMed ID: 11830196
[TBL] [Abstract][Full Text] [Related]
18. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial.
Neuhaus KL; Molhoek GP; Zeymer U; Tebbe U; Wegscheider K; Schröder R; Camez A; Laarman GJ; Grollier GM; Lok DJ; Kuckuck H; Lazarus P
J Am Coll Cardiol; 1999 Oct; 34(4):966-73. PubMed ID: 10520777
[TBL] [Abstract][Full Text] [Related]
19. Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction.
Antman EM; McCabe CH; Braunwald E
Am Heart J; 2002 Feb; 143(2):229-34. PubMed ID: 11835024
[TBL] [Abstract][Full Text] [Related]
20. Approaches to the treatment of unstable angina and non-Q wave myocardial infarction.
Cohen M
Can J Cardiol; 1998 Aug; 14 Suppl E():11E-14E. PubMed ID: 9779027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
